Tamarly Intelligence
Company · CLDX (NASDAQ - All Markets)

Celldex Therapeutics, Inc.

In Vitro & In Vivo Diagnostic Substances

Share this pageLinkedInXEmail
Key figures
Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Institutional holders
253 at 30 Jun 2026 (228 the quarter before) · Who holds it
SEC number
744218

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 1 Oct 2026

Questions and answers

Where is Celldex Therapeutics, Inc. listed?
Celldex Therapeutics, Inc. trades as CLDX on NASDAQ - All Markets. Tamarly shows no share prices.
How many institutions hold Celldex Therapeutics, Inc.?
253 institutional holders reported it on SEC Form 13F for the period ended 30 Jun 2026, against 228 the quarter before.
With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Celldex Therapeutics, Inc.: CLDX, filings, holders and country risk | Tamarly